Yesterday a brand new research was launched exhibiting that sufferers on Eli Lilly’s Zepbound (tirzepatide) misplaced weight however regained a significant share after being switched to placebo. Eli Lilly inventory “tumbled” on the information, e.g. right here and right here or see beneath. In different phrases, Eli Lilly inventory fell when traders realized that to maintain the burden off sufferers must proceed to take Zepbound for all times. Hmmm…that actually violates what the person on the street thinks about pharmaceutical corporations and income. Chris Rock, for instance, says the cash isn’t within the remedy, the cash’s within the comeback. If that’s the case, shouldn’t this have been nice information for Eli Lilly?
So why did Eli Lilly inventory fall? May it’s that the Chris Rock and the person on the street are mistaken? I’ll go away this as an train for the reader.
The put up A Weighty Economics Puzzle appeared first on Marginal REVOLUTION.